Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 381

1.

Antidepressants for insomnia in adults.

Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S.

Cochrane Database Syst Rev. 2018 May 14;5:CD010753. doi: 10.1002/14651858.CD010753.pub2. [Epub ahead of print] Review.

PMID:
29761479
2.

Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis.

Zwink N, Jenetzky E.

Orphanet J Rare Dis. 2018 May 10;13(1):75. doi: 10.1186/s13023-018-0789-3. Review.

3.

Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis.

Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Chen W, Chen L, Yang MX.

Braz J Med Biol Res. 2018;51(7):e7218. doi: 10.1590/1414-431x20187218. Epub 2018 May 7.

4.

Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.

Siskind DJ, Lee M, Ravindran A, Zhang Q, Ma E, Motamarri B, Kisely S.

Aust N Z J Psychiatry. 2018 May 1:4867418772351. doi: 10.1177/0004867418772351. [Epub ahead of print]

PMID:
29732913
5.
6.

Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

Agabio R, Trogu E, Pani PP.

Cochrane Database Syst Rev. 2018 Apr 24;4:CD008581. doi: 10.1002/14651858.CD008581.pub2. Review.

PMID:
29688573
7.

The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews.

Monden R, Roest AM, van Ravenzwaaij D, Wagenmakers EJ, Morey R, Wardenaar KJ, de Jonge P.

J Affect Disord. 2018 Aug 1;235:393-398. doi: 10.1016/j.jad.2018.04.040. Epub 2018 Apr 6.

PMID:
29677603
8.

Association between psychotropic medications and presence of sleep bruxism: A systematic review.

Melo G, Dutra KL, Rodrigues Filho R, Ortega AOL, Porporatti AL, Dick B, Flores-Mir C, De Luca Canto G.

J Oral Rehabil. 2018 Apr 16. doi: 10.1111/joor.12633. [Epub ahead of print] Review.

PMID:
29663484
9.

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis.

Furukawa TA, Maruo K, Noma H, Tanaka S, Imai H, Shinohara K, Ikeda K, Yamawaki S, Levine SZ, Goldberg Y, Leucht S, Cipriani A.

Acta Psychiatr Scand. 2018 Apr 3. doi: 10.1111/acps.12886. [Epub ahead of print]

PMID:
29611870
10.

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

Baandrup L, Ebdrup BH, Rasmussen JØ, Lindschou J, Gluud C, Glenthøj BY.

Cochrane Database Syst Rev. 2018 Mar 15;3:CD011481. doi: 10.1002/14651858.CD011481.pub2. Review.

PMID:
29543325
11.

Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Barić H, Đorđević V, Cerovečki I, Trkulja V.

Adv Ther. 2018 Mar;35(3):261-288. doi: 10.1007/s12325-018-0680-6. Epub 2018 Mar 5. Review.

PMID:
29508154
12.

Guidelines on treatment of perinatal depression with antidepressants: An international review.

Molenaar NM, Kamperman AM, Boyce P, Bergink V.

Aust N Z J Psychiatry. 2018 Apr;52(4):320-327. doi: 10.1177/0004867418762057. Epub 2018 Mar 5.

13.

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.

Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21.

14.

A systematic review of evidence-based treatment strategies for obsessive-compulsive disorder resistant to first-line pharmacotherapy.

Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G.

Curr Med Chem. 2017 Dec 22. doi: 10.2174/0929867325666171222163645. [Epub ahead of print]

PMID:
29278206
15.

Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis.

Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, Cowen PJ, Geddes JR, Stein DJ.

Psychol Med. 2017 Dec 19:1-10. doi: 10.1017/S003329171700349X. [Epub ahead of print]

PMID:
29254516
16.

Management of Treatment-Resistant Panic Disorder.

Perna G, Caldirola D.

Curr Treat Options Psychiatry. 2017;4(4):371-386. doi: 10.1007/s40501-017-0128-7. Epub 2017 Oct 24. Review.

17.

Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.

Wagner G, Schultes MT, Titscher V, Teufer B, Klerings I, Gartlehner G.

J Affect Disord. 2018 Mar 1;228:1-12. doi: 10.1016/j.jad.2017.11.056. Epub 2017 Nov 16. Review.

PMID:
29197738
18.

Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.

Lee Y, Rosenblat JD, Lee J, Carmona NE, Subramaniapillai M, Shekotikhina M, Mansur RB, Brietzke E, Lee JH, Ho RC, Yim SJ, McIntyre RS.

J Affect Disord. 2018 Feb;227:406-415. doi: 10.1016/j.jad.2017.11.003. Epub 2017 Nov 7. Review.

PMID:
29154157
19.

Use of oral antidepressants in patients with chronic pruritus: A systematic review.

Kouwenhoven TA, van de Kerkhof PCM, Kamsteeg M.

J Am Acad Dermatol. 2017 Dec;77(6):1068-1073.e7. doi: 10.1016/j.jaad.2017.08.025. Epub 2017 Oct 21. Review.

PMID:
29033248
20.

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.

Dold M, Bartova L, Rupprecht R, Kasper S.

Psychother Psychosom. 2017;86(5):283-291. doi: 10.1159/000477770. Epub 2017 Sep 14.

PMID:
28903107

Supplemental Content

Loading ...
Support Center